Added to YB: 2026-08-13
Pitch date: 2026-08-11
FRE.DE [neutral]
Fresenius SE & Co. KGaA
-0.85%
current return
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients in North America, Europe, the Asia-Pacific, Latin America, and Africa.
Market Cap
EUR 26.6B
Pitch Price
EUR 47.22
Price Target
N/A
Dividend
2.23%
EV/EBITDA
11.05
P/E
16.99
EV/Sales
1.61
Sector
Health Care Providers and Services
Category
growth
Fresenius (FRE Germany): Kabi's growth businesses improve the earnings mix
FRE.DE (update): Solid Q2, rev in line, EBIT/EPS ahead. Kabi +7% organic led by Growth Vectors +12% (Biopharma +38%, MedTech +11%, Nutrition +5%); Growth Vector EBIT +41% to €234M, 17.9% margin. Traditional Pharma soft (+1%, US pricing). Helios Germany accelerated to +6%. Improving mix; raised Kabi & group '26 rev/EBIT outlook.
Read full article (2 min)